INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.12M
5,277 sh
May 18, 2026May 20, 2026
Page 786 of 1737
← PrevNext →
traded May 18, 2026
+2d
SEC Form 4

Evidence

17
HQ
Hu QichaoDirector, CEO & CHAIRMAN, 10% Owner
SESSES AI Corp
Grant or award
A—
1.50M sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
KS
Kereere SuzanPresident, Global Markets
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
3,962 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

16
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$1,747
380 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

16
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$257K
34.3K sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

16
IC
Iriarte Esteban CDirector
ADARRAY DIGITAL INFRASTRUCTURE, INC.
Grant or award
A$95K
1,873 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

16
AS
Arora SumeetChief Product Officer
TDCTERADATA CORP /DE/
Open-market sale · 10b5-1 plan
SELL$495K
15.0K sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

16
PP
PWP VoteCo Professionals LPDirector
PWPPerella Weinberg Partners
Other acquisition or disposition
J$38K
1.91M sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

15
EJ
Ederer JohnChief Financial Officer
TDCTERADATA CORP /DE/
Tax withholding
F$438K
13.4K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

15
KA
Kharsansky AlanChief Technology Officer
SATLSatellogic Inc.
Option exercise
M—
87.1K sh
May 14, 2026May 20, 2026
traded May 14, 2026
+6dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$541K
2,400 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MA
Maheshwari AnshulChief Financial Officer
SIBNSI-BONE, Inc.
Open-market sale
SELL$32K
2,189 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$426K
1,848 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MA
Maheshwari AnshulChief Financial Officer
SIBNSI-BONE, Inc.
Open-market sale
SELL$36K
2,477 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$421K
1,996 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$280K
1,189 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
SA
Sander Dale A.CFO and Chief Corp. Dev. Off
HUMAHumacyte, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
45.9K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$710K
3,247 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$662K
2,841 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$391K
1,782 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$520K
2,356 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$538K
2,320 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$257K
1,158 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
PJ
Parikh Shamik JChief Medical Officer
HUMAHumacyte, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
45.9K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$530K
2,375 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
5,156 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
OT
O'Brien Robert TDirector
TILEINTERFACE INC
Grant or award
A—
4,461 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
6,320 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
KD
Kasarda John D.Director
ODFLOLD DOMINION FREIGHT LINE, INC.
Grant or award
A—
859 sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

13
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
7,250 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$16K
669 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
8,700 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Option exercise
M—
5,551 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
KR
Kappus Anthony RayGM & Chief Operating Officer
UPWKUPWORK, INC
Option exercise
M—
5,114 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
10.7K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
37.5K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
HS
Haller Karen SDirector
CTRICenturi Holdings, Inc.
Grant or award
A—
4,067 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
BV
Barnett ValerieCHIEF LEGAL OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
7,250 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Option exercise
M—
2,416 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
MD
McCombe William D.Chief Financial Officer
CTKBCytek Biosciences, Inc.
Option exercise
M—
8,700 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence